Business ❯ Pharmaceuticals ❯ Drug Development ❯ Market Competition

Patent Issues

Pfizer Strikes U.S. Drug-Pricing Pact, Wins Exemption From 100% Import Tariff

The pact trades price parity commitments plus TrumpRx.gov participation for an exemption from the looming import penalty.